AKOSi004-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	AKOSi004-A
Cite as:	AKOSi004-A (RRID:CVCL_A4DI)
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	18th April 2023
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Translational Neurodegeneration Section "Albrecht Kossel" (AKOS) Contact: Translational Neurodegeneration Section "Albrecht Kossel" (AKOS)
Owner	Translational Neurodegeneration Section "Albrecht Kossel" (AKOS)
External Databases
Cellosaurus	CVCL_A4DI
Wikidata	Q105506389
General Information
Publications	Völkner C et al. Generation of an iPSC line (AKOSi004-A) from fibroblasts of a female adult NPC1 patient, carrying the compound heterozygous mutation p.Val1023Serfs15/p.Gly992Arg and of an iPSC line (AKOSi005-A) from a female adult control individual. Stem cell research. 2020 Dec 15;50:102127. Völkner C et al. Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Niemann-Pick Type C1. International journal of molecular sciences. 2021 Jan 12;22(2). Völkner C et al. Patient-Specific iPSC-Derived Neural Differentiated and Hepatocyte-like Cells, Carrying the Compound Heterozygous Mutation p.V1023Sfs15/p.G992R, Present the "Variant" Biochemical Phenotype of Niemann-Pick Type C1 Disease. International journal of molecular sciences. 2021 Nov 10;22(22). Gaudioso Á et al. Models to study basic and applied aspects of lysosomal storage disorders. Advanced drug delivery reviews. 2022 Nov;190:114532.
* Is the cell line readily obtainable for third parties?	No

hIPSC Derivation

General